文献速递放射性药物与辐射防护

使用锆-89标记的抗β-葡聚糖抗体片段对曲霉感染进行PET显像

PET imaging of Aspergillus infection using Zirconium-89 labeled anti-β-glucan antibody fragments.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2024-05-24

本研究在体外和临床前小鼠模型中评估了靶向真菌细胞壁β-葡聚糖的抗体及其Fab片段检测曲霉感染的效用。两种β-葡聚糖抗体克隆及其抗原结合Fab片段经生物层干涉术和免疫荧光染色验证结合特性,[89Zr]Zr-DFO-HA-βG-Fab在真菌感染小鼠中显示出特异性结合,且真菌感染灶摄取显著高于细菌感染和无菌性炎症。结论为[89Zr]Zr-DFO-HA-βG-Fab可用于体内检测真菌感染。

要点

  • HA-βG-Ab及其Fab片段与β-葡聚糖高亲和力结合,KD分别为0.056 nM和21.5 nM。
  • 完整抗体免疫PET显像清除慢、背景信号高,且在感染/炎症部位非特异性聚集。
  • [89Zr]Zr-DFO-HA-βG-Fab在真菌感染灶的特异性结合显著高于同型对照Fab、细菌感染和无菌性炎症。

核心结论

  • [89Zr]Zr-DFO-HA-βG-Fab可用于体内检测真菌感染。
  • 靶向真菌细胞壁的不同组分是开发真菌特异性PET示踪剂的可行途径。

研究设计与样本

  • 研究在体外和临床前小鼠模型中评估靶向β-葡聚糖的抗体及抗体片段检测曲霉感染的效用。
  • 体外采用生物层干涉术(BLI)和免疫荧光染色检测两种市售β-葡聚糖抗体克隆及其相应抗原结合Fab片段的结合特性。
  • 体内采用PET/CT在小鼠真菌感染、细菌感染和无菌性炎症模型中进行[89Zr]标记抗体/Fab的结合评估。

主要发现

  • HA-βG-Ab与其Fab(HA-βG-Fab)与β-葡聚糖高亲和力结合,KD分别为0.056 nM和21.5 nM。
  • 免疫荧光染色和体外结合实验验证了与真菌细胞壁的结合。
  • 完整抗体免疫PET显像显示清除慢、背景信号高,并在感染/炎症部位出现非特异性聚集。
  • [89Zr]Zr-DFO-HA-βG-Fab与同型对照Fab相比在真菌感染部位显示特异性结合,且真菌感染灶摄取显著高于细菌感染和无菌性炎症。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Invasive fungal diseases, such as pulmonary aspergillosis, are common life-threatening infections in immunocompromised patients and effective treatment is often hampered by delays in timely and specific diagnosis. Fungal-specific molecular imaging ligands can provide non-invasive readouts of deep-seated fungal pathologies. In this study, the utility of antibodies and antibody fragments (Fab) targeting β-glucans in the fungal cell wall to detect Aspergillus infections was evaluated both in vitro and in preclinical mouse models. METHODS: The binding characteristics of two commercially available β-glucan antibody clones and their respective antigen-binding Fabs were tested using biolayer interferometry (BLI) assays and immunofluorescence staining. In vivo binding of the Zirconium-89 labeled antibodies/Fabs to fungal pathogens was then evaluated using PET/CT imaging in mouse models of fungal infection, bacterial infection and sterile inflammation. RESULTS: One of the evaluated antibodies (HA-βG-Ab) and its Fab (HA-βG-Fab) bound to β-glucans with high affinity (KD = 0.056 & 21.5 nM respectively). Binding to the fungal cell wall was validated by immunofluorescence staining and in vitro binding assays. ImmunoPET imaging with intact antibodies however showed slow clearance and high background signal as well as nonspecific accumulation in sites of infection/inflammation. Conversely, specific binding of [89Zr]Zr-DFO-HA-βG-Fab to sites of fungal infection was observed when compared to the isotype control Fab and was significantly higher in fungal infection than in bacterial infection or sterile inflammation. CONCLUSIONS: [89Zr]Zr-DFO-HA-βG-Fab can be used to detect fungal infections in vivo. Targeting distinct components of the fungal cell wall is a viable approach to developing fungal-specific PET tracers.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Lai J, Shah S, Martinez-Orengo N, et al. PET imaging of Aspergillus infection using Zirconium-89 labeled anti-β-glucan antibody fragments. Eur J Nucl Med Mol Imaging. 2024. PMID: 38787397. doi:10.1007/s00259-024-06760-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。